Artialis is a European CRDO providing end-to-end R&D solutions for healthy aging, from preclinical to post-marketing, with a broad biomarker portfolio.
About
At Artialis, we help turn scientific innovation into real-world solutions for healthy aging. As a European Contract Research and Development Organization (CRDO) with more than 15 years on the market we specialize in preclinical, clinical, and post-marketing research, providing tailored support at every stage of product development.
Since 2010, we’ve been working with pharmaceutical, medical device, and nutraceutical companies to validate products that promote mobility, metabolic health, cognitive function, and overall well-being.
From in-vitro and in-vivo studies to clinical trials and post-market evaluations, we offer a comprehensive, customized approach that aligns with regulatory requirements while keeping research efficient, precise, and impactful.
Since 2010, we’ve been working with pharmaceutical, medical device, and nutraceutical companies to validate products that promote mobility, metabolic health, cognitive function, and overall well-being.
From in-vitro and in-vivo studies to clinical trials and post-market evaluations, we offer a comprehensive, customized approach that aligns with regulatory requirements while keeping research efficient, precise, and impactful.
